RESÚMENES ENERO 2009

.

Basic Neuroscience & Pharmacology

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia

Oliver D. Howes, Andrew J. Montgomery, Marie-Claude Asselin, Robin M. Murray, Isabel Valli, Paul Tabraham, Elvira Bramon-Bosch, Lucia Valmaggia, Louise Johns, Matthew Broome, K. McGuire, FRCPsych, Paul M. Grasby

Arch Gen Psychiatry. 2009;66(1):13-20

 

3! - Sex Differences and the Impact of Steroid Hormones on the Developing Human Brain

Susanne Neufang, Karsten Specht, Markus Hausmann,Onur Güntürkün, Beate Herpertz-Dahlmann, Gereon R. Fink andKerstin Konrad

Cerebral Cortex 2009 19(2):464-473

 

3 - The Neural Basis of Human Social Values: Evidence from Functional MRI

Roland Zahn, Jorge Moll, Mirella Paiva, Griselda Garrido,Frank Krueger, Edward D. Huey and Jordan Grafma

Cerebral Cortex 2009 19(2):276-283

 

3 - Dissociable Roles for the Ventromedial Prefrontal Cortex and Amygdala in Fear Extinction: NR2B Contribution

Francisco Sotres-Bayon, Llorenç Diaz-Mataix, David E.A. Bush andJoseph E. Leroux

Cerebral Cortex 2009 19(2):474-482 

 

3 - Kainate receptors: Pharmacology, function and therapeutic potential

David E. Jane, David Lodge and Graham L. Collingridge

Neuropharmacology. Volume 56, Issue 1, January 2009, Pages 90-113 

3 - GABAA receptors: Subtypes provide diversity of function and pharmacology

Richard W. Olsen and Werner Sieghart

Neuropharmacology. Volume 56, Issue 1, January 2009, Pages 141-148 

3 - Conserved site for neurosteroid modulation of GABAA receptors

Alastair M. Hosie, Laura Clarke, Helena da Silva and Trevor G. Smart

Neuropharmacology. Volume 56, Issue 1, January 2009, Pages 149-154 

3 - Native glycine receptor subtypes and their physiological roles

Joseph W. Lynch

Neuropharmacology. Volume 56, Issue 1, January 2009, Pages 303-309 

3 - Trajectories of depressive symptoms, dopamine D2 and D4 receptors, family socioeconomic status and social support in adolescence and young adulthood

Guo, Guang; Tillman, Kathryn Harker

Psychiatric Genetics. 19(1):14-26, February 2009

3 - Role of shared genetic and environmental factors in symptoms of depression and body composition

Chi Choy, Wing; Lopez-Leon, Sandra; Aulchenko, Yurii S; Mackenbach, Johan P; Oostra, Ben A; van Duijn, Cornelia M; Janssens, A. Cecile J.W

Psychiatric Genetics. 19(1):32-38, February 2009

3! - Effect of the 5-HTTLPR polymorphism in the serotonin transporter gene on major depressive disorder and related comorbid disorders

Verhagen, Maaike; Meij, Annemarie van der; Janzing, Joost G.E; Arias-Vasquez, Alejandro; Buitelaar, Jan K; Franke, Barbara

Psychiatric Genetics. 19(1):39-44, February 2009

3 - Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives

Emre Bora, Murat Yucel and Christos Pantelis

Journal of Affective Disorders. Volume 113, Issues 1-2, February 2009, Pages 1-20

 

3 - White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging

Jessika E Sussmann, G Katherine S Lymer, James McKirdy, T William J Moorhead, Susana Muñoz Maniega, Dominic Job, Jeremy Hall, Mark E Bastin, Eve CJohnstone, Stephen M Lawrie and Andrew M McIntosh

Bipolar Disorders. Volume 11 Issue 1, Pages 11 - 18

 

3 - A preliminary study of increased amygdala activation to positive affective stimuli in mania

Felix Bermpohl, Umut Dalanay, Thorsten Kahnt, Bastian Sajonz, Hannah Heimann, Roland Ricken, Meline Stoy, Claudia Hägele, Florian Schlagenhauf,Mazda Adli, Jana Wrase, Andreas Ströhle, Andreas Heinz and Michael Bauer

Bipolar Disorders. Volume 11 Issue 1, Pages 70 - 75

 

GRATIS 3! - Variation in dopamine genes influences responsivity of the human reward system

Jean-Claude Dreher, Philip Kohn, Bhaskar Kolachana, Daniel R. Weinberger and Karen Faith Berman

PNAS January 13, 2009 vol. 106 no. 2 617-622

 

3! - Experience-Dependent Epigenetic Modifications in the Central Nervous System

J. David Sweatt

Biological Psychiatry. Volume 65, Issue 3, 1 February 2009, Pages 191-197 

3! - Epigenetic Regulation in Human Brain—Focus on Histone Lysine Methylation

Schahram Akbarian and Hsien-Sung Huang

Biological Psychiatry. Volume 65, Issue 3, 1 February 2009, Pages 198-203 

5 - Gene × Environment Interactions at the Serotonin Transporter Locus

Marcus R. Munafò, Caroline Durrant, Glyn Lewis and Jonathan Flint

Biological Psychiatry. Volume 65, Issue 3, 1 February 2009, Pages 211-219 

3 - Changes of blood lactate levels after repetitive transcranial magnetic stimulation

Giovanna Alagona, Marinella Coco, Giuseppe Rapisarda, Erminio Costanzo, Tiziana Maci, Domenico Restivo, Antonino Maugeri and Vincenzo Perciavalle

Neuroscience Letters. Volume 450, Issue 2, 30 January 2009, Pages 111-113

 

3 - Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression

Anteneh M. Feyissa, Agata Chandran, Craig A. Stockmeier and Beata Karolewicz

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 1, 1 February 2009, Pages 70-75

 

3 - Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder

Ercan Ozdemir, Sevil Cetinkaya, Serpil Ersan, Seda Kucukosman and E. Erdal Ersan

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 1, 1 February 2009, Pages 62-65

 

3 - Serotonin genes and gene–gene interactions in borderline personality disorder in a matched case-control study

Xingqun Ni, David Chan, Kirsten Chan, Shelley McMain and James L. Kennedy

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 1, 1 February 2009, Pages 128-133

 

3 - Investigating the inflammatory phenotype of major depression: Focus on cytokines and polyunsaturated fatty acids

Timothy Dinan, Lee Siggins, Paul Scully, Sinead O’Brien, Paul Ross and Catherine Stanton

Journal of Psychiatric Research. Volume 43, Issue 4, January 2009, Pages 471-476

 

3 - Neuropeptides in depression: Role of VGF

Smita Thakker-Varia and Janet Alder

Behavioural Brain Research. Volume 197, Issue 2, 11 February 2009, Pages 262-278

 

3 - Nuclear and Mitochondrial Genome Defects in Autisms

Moyra Smith, M. Anne Spence, and Pamela Flodman

Annals of the New York Academy of Sciences. 2009; Volume 1151:102 - 132

 

3 - Akt/GSK3 Signaling in the Action of Psychotropic Drugs

Jean-Martin Beaulieu, Raul R. Gainetdinov, and Marc G. Caron

Annual Review of Pharmacology and Toxicology 2009; Vol. 49: 327-347

3! - Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study

Paul Lichtenstein, Benjamin H Yip, Camilla Björk, Yudi Pawitan, Tyrone D Cannon, Patrick F Sullivan and Christina M Hultman

The Lancet. Volume 373, Issue 9659, 17 January 2009-23 January 2009, Pages 234-239

 

GRATIS 3 - Psychosocial stress reversibly disrupts prefrontal processing and attentional control

C. Liston, B. S. McEwen and B. J. Casey

PNAS January 20, 2009 vol. 106 no. 3 912-917

 

3 - Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Charles L. Raison, Andrey S. Borisov, Matthias Majer, Daniel F. Drake, Giuseppe Pagnoni, Bobbi J. Woolwine, Gerald J. Vogt, Breanne Massung and Andrew H. Miller

Biological Psychiatry. Volume 65, Issue 4, 15 February 2009, Pages 296-303

3 - Neurophysiological Correlates of Borderline Personality Disorder: A Transcranial Magnetic Stimulation Study




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Sven Barnow, Kathleen A. Völker, Bertram Möller, Harald J. Freyberger, Carsten Spitzer, Hans J. Grabe and Zafiris J. Daskalakis

Biological Psychiatry. Volume 65, Issue 4, 15 February 2009, Pages 313-318

3 - Hypothalamus–Pituitary–Adrenal Axis Hyperresponsiveness Is Associated with Increased Social Avoidance Behavior in Social Phobia




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Karin Roelofs, Jacobien van Peer, Ed Berretty, Paula de Jong, Philip Spinhoven and Bernet M. Elzinga

Biological Psychiatry. Volume 65, Issue 4, 15 February 2009, Pages 336-343

3 - Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter Polymorphism




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Francis E. Lotrich, Robert E. Ferrell, Mordechai Rabinovitz and Bruce G. Pollock

Biological Psychiatry. Volume 65, Issue 4, 15 February 2009, Pages 344-348

3 - Amygdala Function and 5-HTT Gene Variants in Adolescent Anxiety and Major Depressive Disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jennifer Y.F. Lau, David Goldman, Beata Buzas, Stephen J. Fromm, Amanda E. Guyer, Colin Hodgkinson, Christopher S. Monk, Eric E. Nelson, Pei-Hong Shen, Daniel S. Pine and Monique Ernst

Biological Psychiatry. Volume 65, Issue 4, 15 February 2009, Pages 349-355

GRATIS 3! - Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia

Susan Whitfield-Gabrieli, Heidi W. Thermenos, Snezana Milanovic, Ming T. Tsuang, Stephen V. Faraone, Robert W. McCarley, Martha E. Shenton, Alan I. Green, Alfonso Nieto-Castanon, Peter LaViolette, Joanne Wojcik, John D. E. Gabrieli and Larry J. Seidman

PNAS January 27, 2009 vol. 106 no. 4 1279-1284

 

3 - Factors associated with resistance to dementia despite high Alzheimer disease pathology

D. Erten-Lyons, R. L. Woltjer, H. Dodge, R. Nixon, R. Vorobik, J. F. Calvert, M. Leahy, T. Montine, and J. Kaye

NEUROLOGY 2009;72:354-360

3 - Prefrontal gyral folding and its cognitive correlates in bipolar disorder and schizophrenia

A. M. McIntosh, T. W. J. Moorhead, J. McKirdy, J. Hall, J. E. D. Sussmann, A. C. Stanfield, J. M. Harris, E. C. Johnstone, S. M. Lawrie

Acta Psychiatrica Scandinavica. Volume 119 Issue 3, Pages 192 - 198

 

3 - Regional gray matter reduction and theory of mind deficit in the early phase of schizophrenia: a voxel-based morphometric study

R. Herold, Á. Feldmann, M. Simon, T. Tényi, F. Kövér, F. Nagy, E. Varga, S. Fekete

Acta Psychiatrica Scandinavica. Volume 119 Issue 3, Pages 199 - 208

 

3 - DHEA Lessens Depressive-Like Behavior via GABA-ergic Modulation of the Mesolimbic System

Rotem Genud, Avia Merenlender, Iris Gispan-Herman, Rachel Maayan, Abraham Weizman and Gal Yadid

Neuropsychopharmacology (2009) 34, 577–584

 

3 - Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

Vincenzo Micale, Luigia Cristino, Alessandra Tamburella, Stefania Petrosino, Gian Marco Leggio, Filippo Drago and Vincenzo Di Marzo

Neuropsychopharmacology (2009) 34, 593–606

 

3! - A History of Corticosterone Exposure Regulates Fear Extinction and Cortical NR2B, GluR2/3, and BDNF

Shannon L Gourley, Alexia T Kedves, Peter Olausson and Jane R Taylor

Neuropsychopharmacology (2009) 34, 707–716

 

3 - Olfactory Receptor Neuron Dysfunction in Schizophrenia

Bruce I Turetsky, Chang-Gyu Hahn, Steven E Arnold and Paul J Moberg

Neuropsychopharmacology (2009) 34, 767–774

 

3 - Prodynorphin-Derived Peptides Are Critical Modulators of Anxiety and Regulate Neurochemistry and Corticosterone

Walter Wittmann, Eduard Schunk, Iris Rosskothen, Stefano Gaburro, Nicolas Singewald, Herbert Herzog and Christoph Schwarzer

Neuropsychopharmacology (2009) 34, 775–785

 

3 - Assessment of circadian function in fibroblasts of patients with bipolar disorder

S Yang, H P A Van Dongen, K Wang, Berrettini and M Buc acutean

Molecular Psychiatry (2009) 14, 143–155

 

3! - Identifying blood biomarkers for mood disorders using convergent functional genomics

H Le-Niculescu, S M Kurian, Yehyawi, C Dike, S D Patel, H J Edenberg, M T Tsuang, D R Salomon, J I Nurnberger Jr and A B Niculescu

Molecular Psychiatry (2009) 14, 156–174

 

3 - Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression

T A Klempan, A Sequeira, L Canetti, A Lalovic, C Ernst, J ffrench-Mullen and G Turecki

Molecular Psychiatry (2009) 14, 175–189

 

3 - Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice

H K Caldwell, S L Stephens and W S Young III

Molecular Psychiatry (2009) 14, 190–196

 

GRATIS 3! - What Stress Does to Your Brain: A Review of Neuroimaging Studies

Katarina Dedovic, Catherine D’Aguiar, Jens C Pruessner

Can J Psychiatry. 2009;54(1):6–15

 

GRATIS 3! - Imaging Stress Effects on Memory: A Review of Neuroimaging Studies

Anda H van Stegeren

Can J Psychiatry. 2009;54(1):16–27

 

GRATIS 3 - How We See Others: The Psychobiology of Schemas and Transference

Dan J. Stein

CNS Spectr. 2009;14(1):10-13

 

3 - DNA Damage and Repair in Alzheimer’s Disease 
Fabio Coppedè and Lucia Migliore

Current Alzheimer Research. Volume 6, Number 1, February 2009

 

3 - Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands 
E.J. Cobos, J.M. Entrena, F.R. Nieto, C.M. Cendán and E. Del Pozo

Current Neuropharmacology. Volume 6, Number 4, December 2008

.

Regresar a RESÚMENES ENERO 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.